| Literature DB >> 30842108 |
Yin Mo1,2, Ivan Seah3, Pei Shi Priscillia Lye3, Xiang Lee Jamie Kee3, Kien Yee Michael Wong3, Kwan Ki Karrie Ko4, Rick Twee-Hee Ong5, Paul A Tambyah1,6, Alex R Cook5.
Abstract
OBJECTIVES: To study the correlation between knowledge, attitude and practices (KAP) of antibiotic consumption with epidemiology and molecular characteristics of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) carriage, in order to identify modifiable factors and public health interventions to reduce prevalence of multidrug-resistant organism colonisation in the community.Entities:
Keywords: antimicrobial resistance; duration of antibiotic treatment; extended-spectrum beta-lactamase producing enterobacteriaceae
Mesh:
Substances:
Year: 2019 PMID: 30842108 PMCID: PMC6429736 DOI: 10.1136/bmjopen-2018-023859
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Demographics, medical background and antibiotic use of study participants
| Characteristic | N (%) |
| Age (median, IQR) | 53.0 (38.0–66.0) |
| Females | 393 (56.7) |
| Race | |
| Chinese | 513 (74.0) |
| Malay | 78 (11.3) |
| Indian | 83 (12.0) |
| Other ethnicities | 19 (2.7) |
| Education level | |
| Graduate | 88 (12.7) |
| Diploma | 251 (36.2) |
| Secondary | 195 (28.1) |
| Primary | 122 (17.6) |
| No formal education | 37 (5.3) |
| Housing type | |
| One-room, two-room or three-room public housing | 334 (48.2) |
| Four-room or five-room public housing | 327 (47.2) |
| Private landed property | 32 (4.6) |
| Number of occupants in the household | |
| Overall (median, IQR) | 3 (2–4) |
| ≤3 persons | 369 (53.2) |
| 4–5 persons | 257 (37.1) |
| ≥6 persons | 67 (9.7) |
| Comorbidities | |
| Any chronic illnesses | 239 (34.5) |
| Hypertension | 105 (15.2) |
| Hyperlipidemia | 76 (11.0) |
| Diabetes mellitus | 67 (9.7) |
| Recent hospitalisation in the past 1 year | 102 (14.7) |
| Antibiotic consumption | |
| Within past 6 months | 175 (25.3) |
| >6 months ago | 441 (63.6) |
| Never taken antibiotics | 77 (11.1) |
Univariate analysis of demographic characteristics associated with carriage of ceftriaxone-resistant Enterobacteriaceae
| Factors | Total | Carriers | Non-carriers n=225 | P values |
| Age (median, IQR*) | 54.0 (41.0–65.0) | 56.0 (38.8–66.0) | 54.0 (41.0–65.0) | 0.79 |
| Females (%) | 169 (55.4) | 46 (57.5) | 123 (54.7) | 0.76 |
| Ethnicity (%) | ||||
| Chinese | 237 (77.7) | 67 (83.8) | 170 (75.6) | 0.24 |
| Malay | 28 (9.2) | 3 (3.8) | 25 (11.1) | |
| Indian | 30 (9.8) | 7 (8.8) | 23 (10.2) | |
| Others | 10 (3.3) | 3 (3.8) | 7 (3.1) | |
| Education (%) | ||||
| No formal education | 11 (3.6) | 4 (5.0) | 7 (3.1) | 0.45 |
| Primary | 57 (18.7) | 12 (15.0) | 45 (20.0) | |
| Secondary | 93 (30.5) | 21 (26.2) | 72 (32.0) | |
| Tertiary | 110 (36.1) | 31 (38.8) | 79 (35.1) | |
| Graduate | 34 (11.1) | 12 (15.0) | 22 (9.8) | |
| Housing (%) | ||||
| HDB one-room and two-room | 23 (7.5) | 5 (6.2) | 18 (8.0) | 0.75 |
| HDB three-room | 115 (37.7) | 32 (40.0) | 83 (36.9) | |
| HDB four-room | 98 (32.1) | 24 (30.0) | 74 (32.9) | |
| HDB five-room and executive apartment | 47 (15.4) | 11 (13.8) | 36 (16.0) | |
| Landed property | 22 (7.2) | 8 (10.0) | 14 (6.2) | |
| Pets (%) | 33 (10.8) | 7 (8.8) | 26 (11.6) | 0.75 |
| Number of occupants in the household (mean, SD) | 3.6 (1.6) | 3.6 (1.6) | 3.6 (1.6) | 0.71 |
| Stayed overseas for >1 year (%) | 57 (18.7) | 26 (32.5) | 31 (13.8) | <0.001 |
| Stayed in South, East or Southeast Asia for >1 year (%) | 40 (13.1) | 18 (22.5) | 22 (9.8) | 0.01 |
| Travelled in the past >1 year (%) | 178 (58.4) | 47 (58.8) | 131 (58.2) | 1.0 |
| Travelled in South, East or Southeast Asia in the past 1 year (%) | 163 (53.4) | 43 (53.8) | 120 (53.3) | 1.0 |
| Any chronic illnesses (%) | 127 (41.6) | 33 (41.2) | 94 (41.8) | 1.0 |
| Hospitalisation in the past 1 year (%) | 43 (14.1) | 14 (17.5) | 29 (12.9) | 0.41 |
| Previous antibiotics intake (%) | 282 (92.5) | 76 (95.0) | 206 (91.6) | 0.45 |
| Antibiotics in the last 6 months (%) | 85 (27.9) | 23 (28.8) | 62 (27.6) | 0.61 |
| Knowledge score >6 (%) | 89 (29.2) | 33 (41.3) | 56 (24.9) | 0.01 |
| No leftover antibiotics (%) | 211 (69.2) | 63 (78.8) | 148 (65.8) | 0.04 |
Antibiotic susceptibility of the ceftriaxone-resistant isolates
|
|
| Others | Total (n=93) | |
| Piperacillin-tazobactam | 73 (88.0) | 4 (66.7) | 1 (25.0) | 78 (83.9) |
| Cefepime | 35 (42.4) | 3 (50) | 2 (50.0) | 40 (43.0) |
| Aztreonam | 39 (47.0) | 2 (33.3) | 1 (25.0) | 42 (45.2) |
| Amikacin | 82 (98.8) | 5 (83.3) | 4 (100) | 91 (97.8) |
| Gentamicin | 75 (90.4) | 3 (50) | 2 (50.0) | 80 (86.0) |
| Nitrofurantoin | 73 (88.0) | 2 (33.3) | 1 (25.0) | 76 (81.7) |
| Sulfamethoxazole-trimethoprim | 32 (38.6) | 0 (0) | 0 (0) | 32 (34.4) |
| Ciprofloxacin | 48 (57.8) | 4 (66.7) | 1 (25.0) | 53 (57.0) |
| Fosfomycin | 63 (75.9) | 1 (16.7) | 0 (0) | 64 (68.8) |
| Ertapenem | 83 (100) | 6 (100) | 3 (75.0) | 92 (98.9) |
| Meropenem | 83 (100) | 6 (100) | 3 (75.0) | 92 (98.9) |
*Others include Enterobacter species (2), Proteus mirabillis (1), Raoultella ornithinolyitca (1).